Office of the Scientific Director
Mission Statement
The clinical subdivision of the Intramural Research Program strives to perform cutting edge, safe, and ethical research within a coordinated multidisciplinary approach. NIDA-IRP attempts to elucidate the nature of the addictive process; to determine the potential use of new therapies for substance abuse, both pharmacological and psycho-social; and to decipher the long term consequences of drugs of abuse on the development, maturation, function, and structure of the brain, and other organ systems.
Staff
Carlo Contoreggi, M.D.: Clinical Director
Michelle K. Leff, M.D.: Deputy Clinical Director
Thomas Haines, M.S.: Clinical Liaison
Anne Gupman, M.A.: IRB Administrator
Paul Na, P.D.: Deputy Chief of Pharmacy
|
